Results 71 to 80 of about 53,718 (156)

Simultaneous estimation of nebivolol hydrochloride and amlodipine besylate in human plasma employing an innovative HPLC chromatographic method

open access: yesFuture Journal of Pharmaceutical Sciences
Background This study developed and validated a simple, robust, and cost-effective RP-HPLC bioanalytical method for the determination of nebivolol hydrochloride (NBH) and amlodipine besylate (AMB) in human plasma. Briefly, NBH and AMB were extracted from
Kaveri T. Vaditake, Atul A. Shirkhedkar
doaj   +1 more source

Rapid RP-HPLC optimization for efficient determination of nebivolol hydrochloride in bulk and tablet dosage form: application of Box-Behnken design

open access: yesFuture Journal of Pharmaceutical Sciences
Background Nebivolol hydrochloride (NBH) is a β-blocker known for its vasodilatory effects. According to the literature, it is commonly used to treat hypertension.
Kaveri T. Vaditake, Atul A. Shirkhedkar
doaj   +1 more source

Comparative Study of Antihypertensive Drugs Amlodipine Besylate /Metoprolol Succinate and Nebivolol Hydrochloride /Valsartan Combinations in Bilayer Tablets

open access: yes, 2019
The present research is an approach to develop a formulation platform that shall help in minimizing the time and effort taken to develop a drug delivery system.
Emmanuel, C.   +3 more
core   +1 more source

UEG Week 2025 Poster Presentations

open access: yes
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

Voltammetric determination of chlorpromazine hydrochloride and promethazine hydrochloride with the use of multivariate calibration

open access: yes, 2001
The voltammetric behavior of antipsychotic drugs, such as, chlorpromazine hydrochloride and promethazine hydrochloride has been investigated at a glassy carbon electrode in Britton–Robinson buffer of pH 9.
Wang, li   +5 more
core   +1 more source

Nebivolol attenuates cerebral vasospasm both by increasing endothelial nitric oxide and by decreasing oxidative stress in an experimental subarachnoid haemorrhage

open access: yes, 2017
Objective: Evidence suggests that reduction of nitric oxide (NO) bioavailability due to oxidative stress plays a central role in the pathophysiology of cerebral vasospasm after subarachnoid haemorrhage (SAH).
Turkoz, Yusuf   +7 more
core   +1 more source

Nebivolol in the treatment of chronic heart failure

open access: yes, 2007
Angie Veverka, Jennifer L SalinasWingate University School of Pharmacy, Wingate, NC, USAAbstract: Nebivolol is a highly selective beta1-adrenergic blocker that also enhances nitric oxide bioavailability via the L-arginine-nitric oxide pathway, leading to
Angie Veverka, Jennifer L Salinas
core  

Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation

open access: yes, 2006
Robert WeissAndroscoggin Cardiology Associates, Auburn, ME, USAAbstract: Nebivolol is a novel beta1-blocker with a greater degree of selectivity for beta1- adrenergic receptors than other agents in this class and a nitric oxide (NO)-potentiating ...
Robert Weiss
core  

Nebivolol: Endothelium-mediated vasodilating effect

open access: yes, 2001
Nebivolol, a racemic mixture of (S,R,R,R) and (R,S,S,S) enantiomers, is the most beta (1)-selective adrenoceptor antagonist currently available for clinical use.
Ritter, J M
core   +3 more sources

Pharmacological properties of nebivolol

open access: yes, 2019
Nebivolol is a third generation β1 selective beta-blocker with vasodilatory properties which is approved for the treatment of hypertension and heart failure. The vasodilatory effect is nitric-oxide mediated and activated via β3-agonism. Nebivolol has the
Komsuoğlu Çelikyurt, Feride İpek
core   +1 more source

Home - About - Disclaimer - Privacy